DXC Technology Stock Gets IBD Rating Lift

Blockhead
02-06

DXC Technology (DXC) stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 74.

X NOW PLAYING This Is Why The Fed Is Aiming For A Neutral Rate In 2025

IBD's proprietary RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.

Decades of market research reveals that the market's biggest winners typically have an 80 or better RS Rating in the early stages of their moves. See if DXC Technology stock can continue to show renewed price strength and hit that benchmark.


When To Sell Stocks To Lock In Profits And Minimize Losses


Is DXC Technology Stock A Buy?

DXC Technology stock is building a cup without handle with a 24.83 entry. See if the tech stock can clear the breakout price in volume at least 40% higher than normal.

Earnings growth declined in the most recent report from 33% to 7%. But revenue moved higher, from -6% to -5%.

DXC Technology stock earns the No. 24 rank among its peers in the Computer-Technical Services industry group. GitLab Cl A (GTLB), LiveRamp Holdings (RAMP) and Dave (DAVE) are among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

MarketSurge's Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10